917894-23-6Relevant articles and documents
Development of an automated, GMP compliant FASTlab radiosynthesis of [18F]GE-179 for the clinical study of activated NMDA receptors
Khan, Imtiaz,Berg, Tom Christian,Brown, Jane,Bhalla, Rajiv,Wilson, Anthony,Black, Andrew,McRobbie, Graeme,Nairne, James,Olsson, Andreas,Trigg, William
, p. 183 - 195 (2020/03/11)
N-(2-chloro-5-(S-2-[18F]fluoroethyl)thiophenyl)-N'-(3-thiomethylphenyl)-N'-methylguanidine, ([18F]GE-179), has been identified as a promising positron emission tomography (PET) ligand for the intra-channel phencyclidine (PCP) binding
ALKYLATION METHOD
-
, (2017/12/09)
The present invention relates to a method of radiochemical synthesis which is useful in the synthesis of a positron emission tomography (PET) tracer.
METHOD OF SYNTHESIS
-
, (2011/12/02)
The present invention provides a method for the preparation of a radiolabeiied guanidine derivative, in particular wherein the radiolabeiied guanidine derivative is a positron emission tomography (PET) tracer. Certain intermediates useful in said method a
Synthesis and in vitro evaluation of 18F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET
Robins, Edward G.,Zhao, Yongjun,Khan, Imtiaz,Wilson, Anthony,Luthra, Sajinder K.,?rstad, Erik
supporting information; experimental part, p. 1749 - 1751 (2010/08/20)
Two S-[18F]fluoroalkylated diarylguanidines were synthesized and evaluated in vitro as potential tracers for imaging of N-methyl-d-aspartate receptors (NMDARs) with positron emission tomography (PET). [18F]1 and [18F]10 we
IMAGING 18F OR 11C-LABELLED ALKYLTHIOPHENYL GUANIDINES
-
, (2010/11/25)
The invention provides a compound of formula (I); or a salt or solvate thereof, wherein: R1 is hydrogen or C1-4alkyl; R2 and R4 are each independently selected from C1-4 alkyl, [11C] C1 4alkyl, and [18F]-C1-4 fluoroalkyl provided that at least one of R2 and R4 is [11C] C1 4alkyl or [18F]-C1-4 fluoroalkyl; and R3 is halo. Such compounds having use for imaging central nervous system receptors.